NYU Langone Health
New York, 10016, United States
Location status: Recruiting
Location contact
Ashley Witzl
CONTACT
Daniel Walsh
CONTACT
Rany Condos, MD
PRINCIPAL_INVESTIGATOR
NCT Number: NCT04527315
COVID-19 is associated with acute pulmonary and cardiac injury. To better understand the degree and severity of cardiopulmonary injury as well as short and long-term sequelae of COVID-19 infection, this study will perform longitudinal study in patients who had recent known diagnosis of COVID-19.
Interested in participating?
Request Info18 year and older
All sexes
Observational
New York, 10016, United States
Location status: Recruiting
Ashley Witzl
CONTACT
Daniel Walsh
CONTACT
Rany Condos, MD
PRINCIPAL_INVESTIGATOR
The objectives for this study include providing structural and function information about lung and heart using chest imaging, MRI, Echo, Spirometry, and blood markers in order to assess severity of cardiopulmonary injury and short- and long-term sequelae of COVID-19 infection as well as assess indicators of mental health and quality of life.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
CONTROL Inclusion Criteria
Exclusion criteria
Any individual who meets any of the following criteria will be excluded from participation to the MRI or x-ray portion of the study:
CONTROL Exclusion Criteria
Patients with any of the following are excluded from as controls:
Various questionnaires will be used to assess short and long-term impacts of depression, anxiety, and other indicators of overall mental health and quality of life
Time frame: Up to 12 months
Inflammatory markers include D-dimer, ferritin, and CRP measurements
Time frame: Up to 12 months
Disease-specific instrument designed to measure impact on overall health, daily life, and perceived well-being in patients with obstructive airways disease. Scores range from 0 to 100, with higher scores indicating more limitations.
Time frame: Up to 12 months
Short form ZBI-12 validated as screening tool in advanced illness including dementia and cancer. Total ZBI-12 score: summation of 12 items (0 to 4 points per item, total score range 0 to 48). The higher the score, the higher the burden.
Contact information is provided by the study sponsor or research team.
Ashley Witzl
CONTACT
Daniel Walsh
CONTACT
NYU Langone Health
Other
Assessment of ICU and Non-ICU Survivors: A Creation of a COVID Survivorship Database
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04652115
COVID-19, Coronaviridae Infections
Boston, Massachusetts, United States
View Trial DetailsNCT04746183
COVID-19, Coronaviridae Infections
Cape Town, South Africa
View Trial DetailsNCT04956445
COVID-19, Chronic Disease
New Orleans, Louisiana, United States
View Trial DetailsNCT04815096
COVID-19, Coronaviridae Infections
San Francisco, California, United States
View Trial Details